© 2021 KSUT Public Radio
KSUT-web-headerv2880R1.png
NPR News and Music Discovery for the Four Corners
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
KSUT Public Radio wants to keep you updated on the latest news about COVID-19.Listen each day for reporting from NPR, KSUT, and other trustworthy news sources. You can find an ongoing feed of stories about the pandemic below.Links to valuable COVID-related resourcesLive updates of NPR's coronavirus coverage 00000179-f17a-de1b-a9f9-f3fa3e060000

COVID-19 Immunity May Last A Lifetime After Vaccine Or Prior Infection, New Study Finds

A registered nurse draws a dose from a vial of the Johnson & Johnson COVID-19 vaccine. (Michael Ciaglo/Getty Images)
A registered nurse draws a dose from a vial of the Johnson & Johnson COVID-19 vaccine. (Michael Ciaglo/Getty Images)

A new study that focused on the immune response to COVID-19 in patients who contracted mild cases found that antibody production lasts up to a year and may last a lifetime.

Vaccines heighten the antibody response and are crucial in protecting those who developed asymptomatic COVID-19 or never contracted the virus at all, the study finds.

Host Tonya Mosley speaks with Dr. Ali Ellebedy, senior author on the study and professor of pathology and immunology at the Washington University of St. Louis, about his findings.

This article was originally published on WBUR.org.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Related Stories